PSY5 A MARKOV MODEL TO ESTIMATE THE EFFECT OF CANAKINUMAB ON THE PROGRESSION OF AA AMYLOIDOSIS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC-FEVER SYNDROMES (CAPS)
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72954-0
https://www.valueinhealthjournal.com/article/S1098-3015(11)72954-0/fulltext
Title :
PSY5 A MARKOV MODEL TO ESTIMATE THE EFFECT OF CANAKINUMAB ON THE PROGRESSION OF AA AMYLOIDOSIS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC-FEVER SYNDROMES (CAPS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72954-0&doi=10.1016/S1098-3015(11)72954-0
First page :
A460
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1112